OPEN The New England journal of medicine | 6 Nov 2012
ME Farkouh, M Domanski, LA Sleeper, FS Siami, G Dangas, M Mack, M Yang, DJ Cohen, Y Rosenberg, SD Solomon, AS Desai, BJ Gersh, EA Magnuson, A Lansky, R Boineau, J Weinberger, K Ramanathan, JE Sousa, J Rankin, B Bhargava, J Buse, W Hueb, CR Smith, V Muratov, S Bansilal, S King, M Bertrand and V Fuster
In some randomized trials comparing revascularization strategies for patients with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than percutaneous coronary intervention (PCI). We sought to discover whether aggressive medical therapy and the use of drug-eluting stents could alter the revascularization approach for patients with diabetes and multivessel coronary artery disease.
* Data courtesy of Altmetric.com